Screening for type 2 diabetes mellitus

Screening for type 2 diabetes mellitus: a cost-effectiveness analysis.

BACKGROUND No randomized, controlled trial of screening for diabetes has been conducted. In the absence of direct evidence, cost-effectiveness models may provide guidance about preferred screening strategies. OBJECTIVE To estimate the incremental cost-effectiveness of 2 diabetes screening strategies: screening targeted to people with hypertension and universal screening. DESIGN Markov model...

Screening for type 2 diabetes mellitus in adults.

DESCRIPTION Updated U.S. Preventive Services Task Force (USPSTF) recommendation about screening for type 2 diabetes mellitus in adults. METHODS To estimate the balance of benefits and harms of screening, the USPSTF updated its 2003 evidence review, adding evidence from new trials as well as updates on earlier studies. The review for this current recommendation focused on evidence that early t...

Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus.

DESCRIPTION Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. METHODS The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. POPULATION This ...

Type 2 diabetes mellitus in young need for early screening.

Type 2 diabetes mellitus (T2DM) has increased dramatically throughout the world in recent years. This increase has also affected the young, such that over the last decade, the rise in the number of children and youth with T2DM has been labeled an epidemic. The main reason for this epidemic is the spurt in childhood obesity worldwide. This is linked to the global economic growth and changes in l...

Screening for type II diabetes mellitus.